Literature DB >> 7442948

Biochemical investigations into the mode of action of trazodone.

S Clements-Jewery, P A Robson, L J Chidley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7442948     DOI： 10.1016/0028-3908(80)90197-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  12 in total

1.  Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats.

Authors:  Jehangir J Balsara; Sujata A Jadhav; Rajani K Gaonkar; Ramona V Gaikwad; Jagdish H Jadhav
Journal:  Psychopharmacology (Berl)       Date:  2004-12-22       Impact factor: 4.530

2.  Effects of serotonin receptor antagonists on PAG stimulation induced aversion: different contributions of 5HT1, 5HT2 and 5HT3 receptors.

Authors:  F Jenck; C L Broekkamp; A M Van Delft
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  A study of the sensitivity of rat brain alpha 2-adrenoceptors during chronic antidepressant treatments.

Authors:  M F Sugrue
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

4.  Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone.

Authors:  V Ventafridda; C Bonezzi; A Caraceni; F De Conno; G Guarise; G Ramella; L Saita; V Silvani; M Tamburini; F Toscani
Journal:  Ital J Neurol Sci       Date:  1987-12

5.  Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Trazodone--a comparison of single night-time and divided daily dosage regimens.

Authors:  D Brooks; W Prothero; N Bouras; P K Bridges; C M Jarman; S I Ankier
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Trazodone for deafferentation pain. Comparison with amitriptyline.

Authors:  V Ventafridda; A Caraceni; L Saita; C Bonezzi; F De Conno; G Guarise; G Ramella; V Silvani; M Tamburini; F Toscani
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Mianserin and trazodone for cardiac patients with depression.

Authors:  C Bucknall; D Brooks; P V Curry; P K Bridges; N Bouras; S I Ankier
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 9.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 10.  Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.